Updates on management of gastric cancer

FM Johnston, M Beckman - Current oncology reports, 2019 - Springer
Abstract Purpose of Review Gastric adenocarcinoma is the fifth most common and the third
most lethal cancer worldwide. Surgery is the only chance of cure, but recurrence is common …

Recent progress in multidisciplinary treatment for patients with esophageal cancer

M Watanabe, R Otake, R Kozuki, T Toihata… - Surgery today, 2020 - Springer
Esophageal cancer is one of the most aggressive gastrointestinal cancers. This review
focuses on eight topics within the multidisciplinary approach for esophageal cancer. As …

Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆

R Obermannová, M Alsina, A Cervantes… - Annals of …, 2022 - annalsofoncology.org
Oesophageal cancer is the seventh most common cancer worldwide, with 604 000 new
cases diagnosed in 2020. It is the sixth most common cause of cancer-related mortality, with …

Ten-year outcome of neoadjuvant chemoradiotherapy plus surgery for esophageal cancer: the randomized controlled CROSS trial

BM Eyck, JJB van Lanschot, MCCM Hulshof… - Journal of Clinical …, 2021 - ascopubs.org
PURPOSE Preoperative chemoradiotherapy according to the chemoradiotherapy for
esophageal cancer followed by surgery study (CROSS) has become a standard of care for …

Treatment of locally advanced esophageal carcinoma: ASCO guideline

MA Shah, EB Kennedy, DV Catenacci… - Journal of Clinical …, 2020 - ascopubs.org
PURPOSE To develop an evidence-based clinical practice guideline to assist in clinical
decision making for patients with locally advanced esophageal cancer. METHODS ASCO …

Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction …

JV Reynolds, SR Preston, B O'Neill… - The Lancet …, 2023 - thelancet.com
Background The optimum curative approach to adenocarcinoma of the oesophagus and
oesophagogastric junction is unknown. We aimed to compare trimodality therapy …

Advances in the curative management of oesophageal cancer

JC Bolger, CL Donohoe, M Lowery… - British Journal of …, 2022 - nature.com
The incidence of oesophageal cancer, in particular adenocarcinoma, has markedly
increased over the last four decades with adenocarcinoma becoming the dominant subtype …

Esophageal cancer: emerging therapeutics

JE Rogers, M Sewastjanow-Silva… - Expert opinion on …, 2022 - Taylor & Francis
Introduction Esophageal cancer (EC) is a worldwide healthcare concern and represents an
aggressive malignancy. Squamous cell carcinoma (ESCC) and adenocarcinoma (EAC) are …

Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus minimally invasive esophagectomy for resectable esophageal adenocarcinoma, a …

E Tagkalos, PC Van Der Sluis, F Berlth, A Poplawski… - BMC cancer, 2021 - Springer
Background For patients with esophageal adenocarcinoma or cancer of the
gastroesophageal junction, radical esophagectomy with 2-field lymphadenectomy is the …

Surgical treatment of esophageal cancer in the era of multimodality management

AS Borggreve, BF Kingma… - Annals of the New …, 2018 - Wiley Online Library
Over the last decades, the treatment of resectable esophageal cancer has evolved into a
multidisciplinary process in which all players are essential for treatment to be successful …